Newborn Metabolic Screening Programme Advisory Group

Purpose of the group

The Newborn Metabolic Screening Programme Advisory Group was estabilised in 2005 to support the NSU to achieve its vision, namely:

Saving lives, reducing inequalities, and building the Nation’s health by leading the delivery of screening programmes, uncompromising in their quality and trusted by the communities we serve.

Role of the group

The roles of the NMSP Advisory Group include:

providing multidisciplinary advice to the NSU regarding strategic direction, policy and quality standards, funding objectives, legislation reviews and documentation relating to the NMSP
providing multidisciplinary advice to the NMSP Clinical Director regarding technical and operational aspects of the NMSP
sharing responsibility with the NSU, for providing liaison back to their respective formal bodies and consituencies.

To find out more about the NMSP Advisory Group read the group's Terms of Reference.

Members

The group comprises members who collectively have a wide knowledge and experience in the Newborn Metabolic Screening Programme. The membership consists of:

newborn metabolic screening technical expert - Dr Bridget Wilcken
midwife - Catherine Donaldson
consumer - John Forman (NZORD)
paediatrician - Dr Paul Hofman
Chief Advisor Child Youth Health, Ministry of Health - Dr Pat Tuohy
representative from the Commissioner for Children - Mereana Ruri
legal advisor - Dr Fiona McCrimmon
geneticist - Dr Joanne Dixon
Maori advisors - Mina Timutinui and Deb Rowe
Pacific Island advisor - Vacant
NMSP clinical director - Dr Dianne Webster
NMSP metabolic physician - Dr Callum Wilson